Postoperative antibiotic therapy patterns in Benign Prostatic Hyperplasia (BPH) patients

نویسندگان

چکیده

Benign Prostatic Hyperplasia (BPH) is an enlarged prostate disease benign or a condition when the cells are present gland has increased proliferation rate. There several treatment options, including conservative (watchful waiting), medical, and surgery. Antibiotics in BPH cases can be prophylactic antibiotics empiric antibiotics. This study was observational study. The samples were patients who received for period January - November 2019. pattern of antibiotic use shows that most ceftriaxone therapy. Operation on TURP which operation classified into surgery with clean-contaminated category so required. two patterns patients: single (88%) combination (12%). combined given to depending complications patient's clinical condition. occur men mostly occurs at age 60-74 years. Prophylactic therapy patients, namely 1 gr IV once daily 48 (90.6%), broad spectrum. Meanwhile, empirical Ceftriaxone twice (35.6%).

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Benign Prostatic Hyperplasia (bph)

Comprehensive studies show that the holmium laser is ideal for treating BPH. Holmium laser treatments have been the most rigorously investigated BPH techniques. Over 90 articles have been published from 8 randomized clinical trials and over 30 case studies and comparative series. The American, European, British and Australasian urology associations recommend holmium laser for BPH treatment. Hol...

متن کامل

Surgical Options for Benign Prostatic Hyperplasia (BPH)

In 1788 John Hunter first described the pathology of prostatic hyperplasia and its effects on the upper urinary tract. It took a century for the first suprapubic prostatectomy to be carried out in 1887 by AF McGill in Leeds (though Americans tend to claim credit to Fuller in New York in 1894.) The procedure was subsequently p o p u l a r i s e d b y S i r Pe t e r F r e ye r . R e t r o p u b i...

متن کامل

Serum Biochemical and Hematological Parameters in Dogs with Benign Prostatic Hyperplasia (BPH)

BACKGROUND: Clinical prostatic diseases occur in 80% of dogs over 5 and 95% over 9 years of age. . It seems that benign prostatic hyperplasia) BPH) affect Scottish terriers more severely than the other breeds. OBJECTIVES: This study aimed to evaluate the changes of biochemical and hematological parameters in BPH dogs. METHODS: Blood samples were collected from 10 male dogs older than five year...

متن کامل

Benign prostatic hyperplasia (BPH) management in the primary care setting.

Benign prostate hyperplasia (BPH) occurs in up to 50% of men by age 50, and the incidence increases with age. This common clinical problem is diagnosed by history, including the International Prostate Symptom Score (IPSS) questionnaire, and physical examination by digital rectal examination (DRE). Initial management for BPH includes lifestyle modification, and smooth muscle relaxant alpha blo...

متن کامل

Therapeutic Class Overview Benign Prostatic Hyperplasia (BPH) Treatments

Therapeutic Class  Overview/Summary: The agents approved for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH) will be the focus of this review. The α-adrenergic blockers including, alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin, reduce smooth-muscle tone in the prostate and bladder neck decreasing lower urinary tract symptoms (LUTS) secondary to BPH. Alfuzo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Farmasains

سال: 2021

ISSN: ['2086-6968', '2621-9816']

DOI: https://doi.org/10.22219/farmasains.v5i2.13942